ReviewTherapeutics and clinical risk management2026
Knowledge Graphs for Cervical Cancer Across the Care Continuum: From Vaccination and Screening to Personalized Therapy.
Review in Therapeutics and clinical risk management, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cervical cancer remains one of the leading causes of cancer-related death among women worldwide, with a disproportionately high burden in low- and middle-income countries. Infection with human papillomavirus (HPV) is the central etiological factor. Although HPV vaccination and standardized screening can substantially reduce incidence and mortality, major bottlenecks persist in real-world settings, including inadequate coverage, loss to follow-up, data silos, and limited interpretability of algorithms. Knowledge graphs (KGs), characterized by their core "entity-relation" structure, can integrate electronic medical records, HPV genotyping, pathology/imaging, multi-omics, and public health data within a unified semantic framework, and provide traceable evidence chains and reasoning pathways to support clinical decision-making. KGs may become an important enabler. This review summarizes the potential mechanisms and application paradigms of KGs along the full continuum of cervical cancer prevention and care, including primary prevention (vaccination strategies and health education), screening and diagnosis (multimodal data integration, explainable AI, and clinical decision support systems, CDSS), as well as therapeutic decision-making and follow-up management (molecular subtyping, drug associations, and recurrence monitoring. We further highlight key challenges such as ontology standardization, cross-institutional interoperability, dynamic knowledge updating, and reliability of automated knowledge extraction. Future work should focus on establishing reusable, engineering-oriented pathways for the synergy of "KG + large language models (LLMs)/multimodal AI", the development of explainability evaluation metrics, privacy-compliant frameworks, and deployable solutions for primary care settings, in order to accelerate progress toward the global cervical cancer elimination goal.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.